Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Karen Wood, The Ohio State University
ClinicalTrials.gov Identifier:
NCT01420172
First received: August 16, 2011
Last updated: November 18, 2013
Last verified: November 2013
  Purpose

This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.

This study will determine factors influencing pulmonary disease and associated treatment strategies.


Condition Intervention
Post Hematopoietic Stem Cell Transplantation
Other: Data Collection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Further study details as provided by Ohio State University:

Primary Outcome Measures:
  • A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ] [ Designated as safety issue: No ]
    To determine factors influencing pulmonary disease related to HSCT.


Secondary Outcome Measures:
  • A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ] [ Designated as safety issue: No ]
    To review treatment strategies for pulmonary disease post transplant for effectiveness.


Estimated Enrollment: 2000
Study Start Date: August 2011
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Post hematopoietic stem cell transplantation
Patients who were seen post hematopoietic stem cell transplantation between 01Jan2000 and 30Jun2011
Other: Data Collection
Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

A patient record captured during 01Jan2000 and 30Jun2011 from the medical record at The Ohio State University Medical Center who were seen post hematopoietic stem transplant.

Criteria

Inclusion Criteria:

  • Adult patients who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
  • Age > 18 years

Exclusion Criteria:

  • Age <18 years
  • Prisoners
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01420172

Locations
United States, Ohio
The Ohio State University Medical Center
Columbus, Ohio, United States, 43221
Sponsors and Collaborators
Karen Wood
  More Information

Publications:
Responsible Party: Karen Wood, MD, The Ohio State University
ClinicalTrials.gov Identifier: NCT01420172     History of Changes
Other Study ID Numbers: 2011H0214
Study First Received: August 16, 2011
Last Updated: November 18, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on July 22, 2014